The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $809,945 in first-year total cost, median $217,503.
Most frequent study sections
- Special Emphasis Panel[ZMD1 HC (03)]4
Most frequent institutions
- MAD POW MEDIA SOLUTIONS, LLC1
- MEI RESEARCH, LTD1
- REVERAGEN BIOPHARMA, INC.1
- ZANSORS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Evaluation of VBP15 a dissociative steroidal analogue on pain and inflammation1R41MD008829-01 | DAMSKER, JESSEQUEZADO, ZENAIDE MARIA | REVERAGEN BIOPHARMA, INC., MD | $225,000 | ZMD1 |
| 2014 | Improving Asthma Control through mHealth-Based Home Monitoring1R41MD008832-01 | GARY, KEVINHASS, CHRISHORN, IVOR B | MAD POW MEDIA SOLUTIONS, LLC, NH | $224,999 | ZMD1 |
| 2014 | Wireless sensor patch for reducing barriers to in-home sleep apnea screening1R41MD008845-01 | ARNEDT, J. TODD | ZANSORS, LLC, VA | $210,006 | ZMD1 |
| 2014 | Location Initiated Individualized Texts for African American Adolescent Health1R41MD008840-01 | WOOLFORD, SUSAN | MEI RESEARCH, LTD, MN | $149,940 | ZMD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.